A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

Exclusion Criteria

• •Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.
• •An ALT or AST measurement \>2 times the ULN.
• •12-lead ECG demonstrating QTc \>450 msec or a QRS interval \>120 msec at Screening.
• •Subjects at increased risk if dosed with moxifloxacin, according to the product label for moxifloxacin.
• •History of risk factors of QT prolongation or torsades de pointes, congenital deafness and family history of sudden death.